[ad_1]
Stock-market investors have spent most of 2024 celebrating a ”Goldilocks” economy running neither too hot nor too cold. A run of weak U.S. economic data to begin August is now stoking fears that the bears have come home.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...